NephroGenex, Inc. Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31)
NephroGenex, Inc. reported Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) of $0.05 for the 7-month period ending 2004-12-31, per its 10-Q filed 2014-11-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EquityIssuancePerShareAmount · last filed 2014-11-12
- 2004-12-31: Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 7 month $0.05.
USD
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 7 month |
|---|---|
| 2004-12-31 | $0.05 10-Q · filed 2014-11-12 |
USD/shares
| Period end | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) 7 month |
|---|---|
| 2004-12-31 | $0.05 10-Q · filed 2014-11-12 |